  |
|
| 08.30-10.00 |
Injection of Hyaluronic Acid, Osteoarthritis and Evidence Based Medicine:
from Concept to Clinical Application
Breakfast Symposium sponsored by IBSA – GENEVRIER |
| 10.00-11.45 |
SESSION V
Chairmen: F. BERENBAUM & G. HERRERO-BEAUMONT |
10.00-10.30
PL5 |
Invited Lecture
Update on the Management of Osteoarthritis: Clinical and Economic Aspects
J.P. PELLETIER |
| 10.30-11.45 |
Oral Communications of selected abstracts |
10:30-10:40
OC36 |
LONG TERM EVALUATION OF DISEASE PROGRESSION THROUGH THE QUANTITATIVE MAGNETIC RESONANCE IMAGING OF
SYMPTOMATIC KNEE OSTEOARTHRITIS PATIENTS: CORRELATION WITH CLINICAL SYMPTOMS AND RADIOGRAPHIC CHANGES
J-P. Raynauld, J. Martel-Pelletier, M-J. Berthiaume, G. Beaudoin, D. Choquette, B. Haraoui, H. Tannenbaum, J.M. Meyer, J.F. Beary, G.A. Cline, J-P. Pelletier |
10:40-10:50
OC37 |
RADIOLOGIC EVOLUTION OF THE KNEE JOINT: A FOUR-YEAR PROSPECTIVE STUDY
D. Gensburger, M. Arlot, E. Sornay-Rendu, F. Munoz, P.D. Delmas |
10:50-11:00
OC38 |
SCLEROSTIN INHIBITION IN OSTEOPOROTIC RATS COMPLETELY REVERSES ONE YEAR OF OVARIECTOMY-INDUCED SYSTEMIC BONE
LOSS
K. Warmington, M. Ominsky, B. Bolon, R. Cattley, P. Stephens, A. Lawson, D. Lightwood, V. Perkins, H. Kirby, A. Moore, M. Robinson, P.J. Kostenuik, W.S. Simonet, D.L. Lacey, C. Paszty |
11:00-11:10
OC39 |
SB-462795 (RELACATIB), A CATHEPSIN INHIBITOR, PREVENTS THE LOSS OF BONE MASS AT SEVERAL SITES IN OVARIECTOMIZED
CYNOMOLGUS MONKEYS
S. Kumar, C. Jerome, G. Stroup |
11:10-11:20
OC40 |
ZOLEDRONIC ACID SAFETY AND EFFICACY OVER 5 YEARS IN POST-MENOPAUSAL OSTEOPOROSIS
J.P. Devogelaer, P. Burckhardt, P. Meunier, J.M. Kaufman, K. Lippuner, J.J. Body, G. Samsioe, D. Felsenberg, J. Brown, P. Garnero, L. Sanna, C.E. Ortmann, J. Krasnow, E.F. Eriksen, T. Fashola, U. Trechsel |
11:20-11:30
OC41 |
INCIDENT FRACTURES IN PATIENTS WITH INADEQUATE RESPONSE TO ANTIRESORPTIVE OSTEOPOROSIS THERAPY: ONE-YEAR RESULTS
FROM THE OSSO STUDY
C. Cooper, F. Jakob, C. Chinn, E. Martín-Mola, P. Fardellone, S. Adami, N.C. Thalassinos, J. Melo-Gomes, D. Torgerson, T. Nicholson, F. Marín |
11:30-11:40
OC42 |
HOW CAN WE IDENTIFY AND PLAN INTERVENTION AGAINST HIP FRACTURES IN THE POPULATION?
O. Johnell, H. Lundgren, D. Noreen, H. Weibull, T. Lithman |
| 12.15-13.45 |
Reduction of Falls and Osteoporotic Fractures: Plain Vitamin D or
D-Hormone Analogs
Lunch Symposium sponsored by TEVA |
| 13.45-15.00 |
Poster Viewing and Visit of the Exhibition
Poster P300 to P380 |
| 15.00-16.45 |
SESSION VI
organized under the auspices of the Austrian Society For Bone And Mineral
Research
Chairmen: H. BRÖLL & K. KLAUSHOFER |
|
Translation from English to German will be kindly provided by SERVIER Austria
|
| PL6 |
Post-Transplantation Bone Disease: Clinical and Economic Aspects
P. PIETSCHMANN |
| PL7 |
Treatment of Post-Transplantation Bone Disease: Clinical and Economic Aspects
A. FAHRLEITNER-PAMMER |
| PL8 |
Osteoporosis Associated with Chronic Lung Diseases: Clinical and Economic Aspects
H.-P. DIMAI |
| PL9 |
Osteoporosis in Cancer Patients: Clinical and Economic Aspects
H. RESCH |
| 17.00-18.30 |
Outcomes in Post-Menopausal Osteoporosis: from Clinical Evidence to
Regulatory Requirements
Symposium organized by the GREES -
Group for the Respect of Ethics and Excellence in Science |
| 18.30 |
Conclusion and Adjournment of the Congress
P.D. DELMAS - J.-Y. REGINSTER |
 
|
|
|